By Sneha S K April 2 (Reuters) - Immunovant said on Thursday that its therapy failed to reduce eye bulging when tested in ...

Thyroid eye disease is a chronic condition that causes inflammation in your eyes. It affects about 25–50% of people with Graves’ disease, which is an autoimmune disorder that causes an overactive ...

What Does the Thyroid Gland Do? The thyroid is a butterfly-shaped gland located at the front of your neck. It produces hormones that help regulate many of your body’s functions: Thyroid nodules often ...

Please provide your email address to receive an email when new articles are posted on . Until recently, patients with active thyroid eye disease had limited options for treatment of their condition ...

Please provide your email address to receive an email when new articles are posted on . Thyroid eye disease treatments have evolved significantly in recent years. Work is still needed to find durable, ...

Thyroid eye disease (TED) is an inflammatory condition affecting those with thyroid disease. There is no cure, but effective management strategies exist. Thyroid eye disease, or Graves’ ophthalmopathy ...

Credit: Shutterstock. Tepezza is a human insulin-like growth factor-1 receptor inhibitor. The Indications and Usage section of the Tepezza ® (teprotumumab-trbw) prescribing information has been ...

Despite hitting its primary endpoint, Viridian’s thyroid eye disease antibody failed to ease eye bulging to the degree that ...

Around 12% of the United States population will develop some type of thyroid condition in their lifetime. An estimated 20 million Americans are living with some form of thyroid disease. This is an ...

Thyroid eye disease is a chronic autoimmune disorder that inflames tissues behind the eye. Swelling can cause dry, irritated eyes, bulging, light sensitivity, and double vision. Thyroid eye disease ...

Thyroid diseases affect up to 5% of all pregnancies. Adverse pregnancy and neonatal outcomes are increased by maternal thyroid disease and adequate treatment is thought to reduce these risks.

April 2 (Reuters) - Immunovant said on Thursday that its therapy failed to reduce eye bulging when tested in patients with moderate-to-severe thyroid eye disease in two late-stage studies. Shares of ...